TD Asset Management
IDYA icon

TD Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

TD Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.42M Buy
118,670
+75,000
+172% +$2.3M ﹤0.01% 828
2026
Q1 		$1.46M Sell
43,670
-2,370
-5% -$79.5K ﹤0.01% 1035
2025
Q4 		$1.59M Buy
46,040
+19,600
+74% +$625K ﹤0.01% 1031
2025
Q3 		$719K Sell
26,440
-8,596
-25% -$208K ﹤0.01% 1133
2025
Q2 		$736K Hold
35,036
– – ﹤0.01% 1096
2025
Q1 		$574K Sell
35,036
-30,254
-46% -$645K ﹤0.01% 1133
2024
Q4 		$1.68M Sell
65,290
-16,800
-20% -$476K ﹤0.01% 1047
2024
Q3 		$2.53M Sell
82,090
-34,600
-30% -$1.31M ﹤0.01% 960
2024
Q2 		$4.1M Sell
116,690
-65,200
-36% -$2.58M ﹤0.01% 807
2024
Q1 		$7.98M Buy
181,890
+44,200
+32% +$1.9M 0.01% 666
2023
Q4 		$4.9M Buy
137,690
+24,034
+21% +$717K ﹤0.01% 775
2023
Q3 		$3.07M Buy
113,656
+76,528
+206% +$1.94M ﹤0.01% 842
2023
Q2 		$873K Buy
+37,128
New +$763K ﹤0.01% 1155
2023
Q1 		– Sell
-14,502
Closed -$264K – 1444
2022
Q4 		$264K Hold
14,502
– – ﹤0.01% 1368
2022
Q3 		$205K Hold
14,502
– – ﹤0.01% 1399
2022
Q2 		$200K Sell
14,502
-20,400
-58% -$227K ﹤0.01% 1386
2022
Q1 		$391K Sell
34,902
-40,400
-54% -$596K ﹤0.01% 1366
2021
Q4 		$1.78M Buy
75,302
+8,700
+13% +$202K ﹤0.01% 1161
2021
Q3 		$1.7M Buy
66,602
+8,800
+15% +$205K ﹤0.01% 1131
2021
Q2 		$1.42M Buy
57,802
+19,897
+52% +$409K ﹤0.01% 1189
2021
Q1 		$891K Buy
37,905
+14,405
+61% +$278K ﹤0.01% 1283
2020
Q4 		$329K Buy
+23,500
New +$318K ﹤0.01% 1379

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TD Asset Management's IDYA Position: Q2 2026 in Review

TD Asset Management increased its IDEAYA Biosciences (IDYA) stake by 172% in Q2 2026, buying an estimated $2.3M and bringing the position to 118,670 shares worth $4.42M. The position accounts for ﹤0.01% of the portfolio, ranked #828.

TD Asset Management first reported a position in IDYA in Q4 2020 and has held it in 22 quarters since. The position peaked at $7.98M in Q1 2024. 282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • TD Asset Management held 118,670 shares of IDEAYA Biosciences worth $4.42M as of Q2 2026.
  • TD Asset Management bought 75,000 IDEAYA Biosciences shares in Q2 2026, an estimated $2.3M.
  • IDEAYA Biosciences made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #828 holding.
  • TD Asset Management first reported a position in IDEAYA Biosciences in Q4 2020 and has held it in 22 quarters since.
  • TD Asset Management's IDEAYA Biosciences position peaked at $7.98M in Q1 2024.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.